Get the Stockscreener App
0.7431
0.61%
0.0045
Cypherpunk Technologies Inc stock is traded at $0.7431, with a volume of 811.27K.
It is up +0.61% in the last 24 hours and up +8.42% over the past month.
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
See More
Previous Close:
$0.7386
Open:
$0.755
24h Volume:
811.27K
Relative Volume:
0.27
Market Cap:
$66.86M
Revenue:
-
Net Income/Loss:
$4.82M
P/E Ratio:
10.96
EPS:
0.0678
Net Cash Flow:
$-140.90M
1W Performance:
+3.63%
1M Performance:
+8.42%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.7306
$0.79
1-Week Range:
$0.666
$0.79
52-Week Range:
$0.50
$3.6999
Cypherpunk Technologies Inc Stock (CYPH) Company Profile
Name
Cypherpunk Technologies Inc
Sector
Industry
Phone
617 252 4343
Address
47 THORNDIKE STREET, CAMBRIDGE
Compare CYPH vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYPH
Cypherpunk Technologies Inc
|
0.7431 | 66.46M | 0 | 4.82M | -140.90M | 0.0678 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-29-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
| Feb-11-20 | Initiated | Robert W. Baird | Outperform |
| Nov-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-13-19 | Resumed | Raymond James | Outperform |
| Mar-07-17 | Initiated | Ladenburg Thalmann | Buy |
View All
Cypherpunk Technologies Inc Stock (CYPH) Latest News
CYPH.O Technical Analysis & Stock Price Forecast - Intellectia AI
Top Cypherpunk Technologies (CYPH) Competitors 2026 - MarketBeat
Cypherpunk Technologies (CYPH) Stock Forecast and Price Target 2026 - MarketBeat
Cypherpunk Technologies Inc. - AD HOC NEWS
Cypherpunk Technologies (CYPH) director converts 104,500 RSUs to 152,500 share stake - Stock Titan
Cypherpunk (CYPH) director converts 168,750 vested RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) receives 168,750 shares from RSUs - Stock Titan
Director William Li of Cypherpunk (CYPH) receives 168,750 shares from RSU settlements - Stock Titan
RSU settlements give Cypherpunk (CYPH) director 168,750 common shares - Stock Titan
Cypherpunk Technologies (CYPH) director converts 168,750 RSUs into common shares - Stock Titan
Cypherpunk (CYPH) director converts 168,750 RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) gains 168,750 shares via RSU settlements - Stock Titan
Director Loscalzo acquires 168,750 Cypherpunk (CYPH) shares via RSUs - Stock Titan
Director Cavanaugh acquires 168,750 Cypherpunk (CYPH) shares from RSUs - Stock Titan
ZEC Rallies 20% After Cypherpunk Reports First Annual Profit - thedefiant.io
CYPH.O PE Ratio & Valuation, Is CYPH.O Overvalued - Intellectia AI
CYPH.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CYPH.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CYPH Should I Buy - Intellectia AI
CYPH.O Forecast — Price Prediction for 2026. Should I Buy CYPH.O? - Intellectia AI
Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart
Security Notice: Cysic Foundation X Account Breached - Bitget
Cypherpunk reports full year 2025 financial results - marketscreener.com
Cypherpunk Reports Full Year 2025 Financial Results - National Today
Cypherpunk Technologies Reports Transformational 2025 Financial Results - Intellectia AI
Cypherpunk Technologies 10-K: Revenue $0, EPS $0.07 on $4.8M Net Income - TradingView
CYPH: 2025 saw a strategic pivot to Zcash, a return to profitability, and major digital asset gains - TradingView
Cypherpunk Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cypherpunk Technologies (CYPH) pivots to Zcash while advancing cancer drugs - Stock Titan
CYPH: Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress - TradingView
[8-K] CYPHERPUNK TECHNOLOGIES INC. Reports Material Event | CYPH SEC FilingForm 8-K - Stock Titan
Cypherpunk Technologies Inc. (CYPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cypherpunk Technologies Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Cypherpunk Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Cypherpunk (CYPH) after shares stay below $1 minimum bid - Stock Titan
Zcash Open Development Lab announced that it has received $25 million in funding from a group of investors - marketscreener.com
Cypherpunk Technologies: $5 Million Investment In Zcash Open Development Lab To Advance Privacy Infrastructure - Pulse 2.0
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL) - Yellow.com
Cypherpunk Invests $5M in Zcash Company ZODL - Intellectia AI
Cypherpunk Makes $5M Investment into Zcash Open Development Lab - citybiz
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Leap Therapeutics, Inc. Common Stock (CYPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
CYPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CYPH Technical Analysis & Stock Price Forecast - Intellectia AI
CYPH | Cypherpunk Technologies Inc. Common Institutional Ownership - Quiver Quantitative
Zcash Drops 60% as Treasury Buyer Hits Pause - Cointribune
Zcash Slides 60% as Treasury Buying Pauses and Cypherpunk’s Losses Mount - Bitget
Is crypto still cypherpunk? With Miden co-founder Azeem Khan - Yahoo Finance
Zcash Down Over 50% Since Winklevoss-Backed DAT’s Last Purchase - thedefiant.io
Billionaire twins–backed stock surges 100% after buying $50M ‘encrypted Bitcoin’ - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Cypherpunk Technologies Inc Stock (CYPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):